Cargando…
Upregulated Solute Carrier SLC39A1 Promotes Gastric Cancer Proliferation and Indicates Unfavorable Prognosis
BACKGROUNDS: Solute carrier 39A1 (SLC39A1) is an indirect zinc transporter which showed diverse tumor-related functions in different malignancies. Here, we aimed to investigate its expression and role in gastric adenocarcinoma. METHODS: A retrospective gastric adenocarcinoma cohort (n = 154) was col...
Autores principales: | Yu, Dan, Chen, Yong, Luo, Ming, Peng, Yanjin, Yi, Shengen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652071/ https://www.ncbi.nlm.nih.gov/pubmed/36407082 http://dx.doi.org/10.1155/2022/1256021 |
Ejemplares similares
-
Decreased SLC39A1 (Solute carrier family 39 member 1) expression predicts unfavorable prognosis in patients with early-stage hepatocellular carcinoma
por: Zhang, Qinglin, et al.
Publicado: (2021) -
SLC39A10 Upregulation Predicts Poor Prognosis, Promotes Proliferation and Migration, and Correlates with Immune Infiltration in Hepatocellular Carcinoma
por: Ma, Zuyi, et al.
Publicado: (2021) -
Analysis of the prognostic significance of solute carrier (SLC) family 39 genes in breast cancer
por: Liu, Limei, et al.
Publicado: (2020) -
Evaluation of the prognostic values of solute carrier (SLC) family 39 genes for patients with lung adenocarcinoma
por: Zhou, Heng, et al.
Publicado: (2021) -
Upregulation of the solute carrier family 7 genes is indicative of poor prognosis in papillary thyroid carcinoma
por: Shen, Lei, et al.
Publicado: (2018)